EcoDrugPlus

Ttk Protein Kinase

Ensembl ID : ENSEEUG00000013758
Gene Symbol: TTK
1 External references
205 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSEEUG00000001788
Gene Symbol: UGCG
4 External references
212 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSEEUG00000001707
Gene Symbol: YES1
1 External references
259 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSEEUG00000009538
Gene Symbol: ACHE
1 External references
234 Possible Orthologues:

Activin A Receptor Like Type 1

Ensembl ID : ENSEEUG00000012833
Gene Symbol: ACVRL1
1 External references
358 Possible Orthologues:

Adenosine A1 Receptor

Ensembl ID : ENSEEUG00000013996
Gene Symbol: ADORA1
1 External references
275 Possible Orthologues:

Adenosine A2a Receptor

Ensembl ID : ENSEEUG00000001489
Gene Symbol: ADORA2A
1 External references
264 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSEEUG00000014500
Gene Symbol: ADORA2B
1 External references
201 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSEEUG00000008555
Gene Symbol: ADA
1 External references
219 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSEEUG00000012033
Gene Symbol: ADRA1A
1 External references
201 Possible Orthologues:

Adrenoceptor Beta 3

Ensembl ID : ENSEEUG00000000191
Gene Symbol: ADRB3
3 External references
218 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSEEUG00000014346
Gene Symbol: AGER
1 External references
170 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).